Sheikh Haris, Zafar Shakaib, Nawaz Kamran, Ullah Hameed
Department of Anesthesiology, The Aga Khan University, Karachi, Pakistan.
Anesth Pain Med (Seoul). 2025 May 1;20(3):266-76. doi: 10.17085/apm.24159.
BACKGROUND: Laparoscopic cholecystectomy has been associated with moderate to severe intensity pain, especially in the early postoperative period. Among pain modalities, the transversus abdominis plane (TAP) block has favorable results and fewer associated adverse effects. Current evidence also reports that intravenous lidocaine infusion is effective in reducing acute postoperative pain and decreases overall opioid requirement. This study aimed to compare intravenous lidocaine infusion and bilateral subcostal TAP block for postoperative analgesia following laparoscopic cholecystectomy. METHODS: Thirty patients were randomly classified into the control, lidocaine, and TAP block groups. Intravenous lidocaine infusion was used in the lidocaine arm intraoperatively, while bilateral subcostal TAP block was placed in the TAP block arm as an intervention. The primary outcome was 24 h average pain score. Secondary outcomes included rescue analgesic consumption, postoperative nausea and vomiting, and patient satisfaction. RESULTS: Comparative analysis between groups showed that the 24 h mean pain score on the visual analog scale score was significantly decreased in the lidocaine group than the control group (mean difference with 95% confidence interval [CI], 2.47 (1.94, 3.00); P < 0.001). Furthermore, the mean pain score was significantly decreased in the lidocaine group than in the TAP block group (mean difference with 95% CI, 1.14 (0.56, 1.72); P < 0.001). CONCLUSIONS: Intravenous lidocaine infusion is a superior modality for postoperative pain management in laparoscopic cholecystectomy than TAP block or routine management. Lidocaine also helped decrease rescue analgesic consumption and achieved better patient satisfaction.
背景:腹腔镜胆囊切除术与中度至重度疼痛相关,尤其是在术后早期。在各种疼痛治疗方式中,腹横肌平面(TAP)阻滞效果良好且相关不良反应较少。目前的证据还表明,静脉输注利多卡因可有效减轻术后急性疼痛并减少总体阿片类药物需求量。本研究旨在比较静脉输注利多卡因与双侧肋下TAP阻滞用于腹腔镜胆囊切除术后的镇痛效果。 方法:30例患者被随机分为对照组、利多卡因组和TAP阻滞组。利多卡因组术中采用静脉输注利多卡因,而TAP阻滞组采用双侧肋下TAP阻滞作为干预措施。主要结局指标为24小时平均疼痛评分。次要结局指标包括补救性镇痛药物消耗量、术后恶心呕吐及患者满意度。 结果:组间比较分析显示,利多卡因组视觉模拟量表评分的24小时平均疼痛评分较对照组显著降低(平均差值及95%置信区间[CI],2.47(1.94, 3.00);P<0.001)。此外,利多卡因组的平均疼痛评分较TAP阻滞组显著降低(平均差值及95%CI,1.14(0.56, 1.72);P<0.001)。 结论:对于腹腔镜胆囊切除术后的疼痛管理,静脉输注利多卡因是一种优于TAP阻滞或常规管理的方式。利多卡因还有助于减少补救性镇痛药物的消耗量,并获得更好的患者满意度。
Cochrane Database Syst Rev. 2018-6-4
Cochrane Database Syst Rev. 2015-7-16
J Minim Access Surg. 2024-7-1
J Ayub Med Coll Abbottabad. 2018